Aurum Biosciences

Developing novel oxygen carriers for treatment and diagnosis. Uses in stroke, inflammation, oncology, cardiovascular, spinal cord injury and dementia.

[Aurum Biosciences @aurumbioscience]

Learn more about our multi-market distruptive technology, & our initial development in acute stroke in our new video https://t.co/Hdzs6dgqRQ

[Graham Watson @posleadership]

#NHS Scotland spinout aiming to further accelerate growth with Boston Congress presence - an exciting opportunity for ⁦@innoscothealth⁩ investment ⁦@aurumbioscience⁩ https://t.co/STAEariDPA

[Aurum Biosciences @aurumbioscience]

An article from Aurum's Chairman on how @innoscothealth can help support innovation in the NHS. Aurum has received significant support from InnoScot Health on its journey to the clinic.

[Graham Watson @posleadership]

#Healthcare #innovations require collaboration and support via @innoscothealth - https://t.co/fXrU9et90K

[InnoScot Health @innoscothealth]

Scottish biopharmaceutical company and InnoScot Health spin-out @aurumbioscience has been invited to speak at BioTrinity 2024 on 24 April, allowing it to demonstrate the potential of its technology to advance the management of acute stroke patients.

👉 https://t.co/91Wc82Chx0

[Graham Watson @posleadership]

.⁦@innoscothealth⁩ #spinout ⁦⁦@aurumbioscience⁩ looks to further catalyse growth #healthcare #innovation #stroke https://t.co/SUD7TQcW5b

[Aurum Biosciences @aurumbioscience]

Aurum Biosciences have been invited to present at #Biotrinity. CEO Dr David Brennan will be sharing details of Aurum's groundbreaking clinical technology and its use in areas of high unmet medical need.

https://t.co/n5OPQd6TmL

[InnoScot Health @innoscothealth]

A spinout of InnoScot Health, @NHSGGC and @UofGlasgow, @aurumbioscience is developing a novel drug for therapeutics and multiple diagnostics, in areas of unmet clinical need such as stroke, spinal cord injury, and inflammatory imaging.

Read more 👉 https://t.co/91Wc82Chx0

[InnoScot Health @innoscothealth]

Ahead of securing almost £730,000 in funding, @aurumbioscience announced that it had been recognised by the UK’s Innovative Licensing and Access Pathway for ABL-101 and awarded an Innovation Passport, a gateway to the accelerative pathway.

Read more 👉 https://t.co/I7gs9zU7Is

[InnoScot Health @innoscothealth]

Scottish biopharmaceutical company @aurumbioscience has raised almost £730,000 in the first tranche of a new round of funding aimed at further developing its state-of-the-art therapeutic and diagnostic technology and setting up fresh success in 2024.

👉 https://t.co/I7gs9zU7Is

[Scottish Enterprise News @ScotEntNews]

NEWS: Biopharmaceutical company @aurumbioscience raises almost £730k in first tranche of new equity round aimed at further developing its state-of-the-art therapeutic and diagnostic technology. @scotent is among investors ➡️
https://t.co/dPcoO5vPxU

[Graham Watson @posleadership]

Tackling #stroke effectively is a huge medical challenge. I am delighted that @innoscothealth has been a core supporter of @aurumbioscience since its spin out from the #NHS. @RichardLochhead - this is Scottish life science #innovation at its finest.

[Aurum Biosciences @aurumbioscience]

Scottish biopharma company’s state-of-the-art technology attracts £730k in fresh investment #Stroke #SpinalCordInjury #Biotech #Scotland
https://t.co/d2V7AZ7aVW

[InnoScot Health @innoscothealth]

New on our website @posleadership, Executive Chair of InnoScot Health, discusses the necessity for NHS Scotland to retain commercially astute healthcare professionals 👉 https://t.co/M2wcehVWdo

[InnoScot Health @innoscothealth]

The award of the Innovation Passport is recognition that @aurumbioscience's patented ABL-101 platform technology has the potential to offer the first major advancement in the management of acute stroke patients in more than two decades.

Read more 👉 https://t.co/1SaLBpCEaD

[Glasgow City of Science and Innovation @cityofscience]

🏅 Exciting news for #Glasgow's biopharmaceutical sector!

@aurumbioscience has been awarded an Innovation Passport by the UK's Innovative Licensing and Access Pathway for their groundbreaking stroke technology

👇 Read & Comment

https://t.co/zCIgKzrKQV

#Glasgow #Scotland

[Scottish Development International @ScotDevInt]

Glasgow spinout, @aurumbioscience, has been awarded an Innovation Passport for it's state-of-the-art stroke technology 👏

The recognition by the UK’s Innovative Licensing & Access Pathway will help acceletate the firm's tech to market 📈

#ScotlandIsNow
https://t.co/zWsmJFdVeP

[Scottish Enterprise @scotent]

Huge congratulations to Glasgow spinout @aurumbioscience on being awarded an Innovation Passport for its state-of-the-art stroke technology 👏

The 'passport' will help accelerate the commercialisation of the firm's life-saving technology 📈

#Innovation
https://t.co/LiIaXlpyUA

[InnoScot Health @innoscothealth]

.@aurumbioscience, a clinical stage biopharmaceutical company based in Scotland, spun out by InnoScot Health, @NHSGGC and @UofGlasgow, has been awarded an Innovation Passport for its breakthrough stroke technology.

Read more 👉 https://t.co/1SaLBpCEaD

[Herald Business @_HeraldBusiness]

New chief for stroke treatment pioneer @aurumbioscience https://t.co/riJrWGWh7S

[Herald Business @_HeraldBusiness]

There's a new chief appointed | @KristyDorsey https://t.co/riJrWGWh7S

[Herald Business @_HeraldBusiness]

Business Briefing:

◾Hairy Bikers to help boost food, drink tourism in Scotland

◾Scottish stroke treatment pioneer Aurum appoints new chief

◾Scottish firm harnessing artificial intelligence to build workforce

👉https://t.co/pglvkYzMox